WealthTrust Axiom LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,122 filers reported holding NOVARTIS A G in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.

Quarter-by-quarter ownership
WealthTrust Axiom LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$3,380,772
+0.9%
33,1900.0%1.22%
+9.5%
Q2 2023$3,349,242
+9.7%
33,190
-0.0%
1.11%
+6.7%
Q1 2023$3,054,435
+1.4%
33,200
-0.0%
1.04%
-1.0%
Q4 2022$3,013,276
+12.4%
33,215
-5.9%
1.05%
+2.8%
Q3 2022$2,682,000
-10.3%
35,290
-0.3%
1.02%
-4.1%
Q2 2022$2,991,000
-4.6%
35,390
-0.9%
1.07%
+8.9%
Q1 2022$3,134,000
+0.2%
35,720
-0.1%
0.98%
-2.1%
Q4 2021$3,128,000
+6.5%
35,770
-0.4%
1.00%
+0.6%
Q3 2021$2,936,000
-10.7%
35,905
-0.3%
0.99%
-5.8%
Q2 2021$3,287,000
+3.7%
36,030
-2.8%
1.06%
-1.6%
Q1 2021$3,169,000
-10.0%
37,075
-0.6%
1.07%
-16.2%
Q4 2020$3,521,000
+6.4%
37,295
-2.0%
1.28%
-10.2%
Q3 2020$3,308,000
-4.3%
38,044
-3.8%
1.42%
-6.3%
Q2 2020$3,455,000
+3.1%
39,559
-2.7%
1.52%
-7.5%
Q1 2020$3,352,000
-10.8%
40,659
+2.5%
1.64%
+30.9%
Q4 2019$3,756,000
+8.0%
39,672
-0.9%
1.26%
+2.3%
Q3 2019$3,477,000
-5.5%
40,022
-0.7%
1.23%
-3.9%
Q2 2019$3,680,000
-6.0%
40,312
-1.0%
1.28%
-8.2%
Q1 2019$3,913,000
+12.3%
40,706
+0.2%
1.39%
-2.5%
Q4 2018$3,485,000
+1.4%
40,621
+1.8%
1.43%
+23.0%
Q3 2018$3,437,000
+21.1%
39,891
+6.2%
1.16%
+15.8%
Q2 2018$2,837,000
-4.2%
37,566
+2.6%
1.00%
-7.2%
Q1 2018$2,961,000
+41.5%
36,626
+46.9%
1.08%
+38.8%
Q4 2017$2,093,000
-2.3%
24,935
-0.1%
0.78%
-4.5%
Q3 2017$2,143,000
+2.6%
24,968
-0.3%
0.82%
+4.0%
Q2 2017$2,089,000
+59.0%
25,032
+41.4%
0.78%
+63.0%
Q1 2017$1,314,000
+6.7%
17,698
+4.7%
0.48%
+7.6%
Q4 2016$1,231,000
-13.9%
16,908
-6.6%
0.45%
-16.3%
Q3 2016$1,429,000
-5.1%
18,108
-0.8%
0.53%
-7.8%
Q2 2016$1,506,000
+13.9%
18,258
+0.0%
0.58%
+10.9%
Q1 2016$1,322,000
-15.8%
18,2550.0%0.52%
-16.2%
Q4 2015$1,570,000
-7.2%
18,255
-0.8%
0.62%
-11.4%
Q3 2015$1,691,000
-7.0%
18,405
-0.5%
0.70%
+4.6%
Q2 2015$1,819,000
-0.5%
18,505
-0.3%
0.67%
+3.1%
Q1 2015$1,829,000
+5.3%
18,552
-1.1%
0.65%
+5.5%
Q4 2014$1,737,000
-1.6%
18,7520.0%0.62%
-1.1%
Q3 2014$1,765,000
+4.0%
18,7520.0%0.62%
+8.7%
Q2 2014$1,697,000
+12.5%
18,752
+5.7%
0.58%
+5.9%
Q1 2014$1,509,000
+11.3%
17,749
+5.2%
0.54%
+4.0%
Q4 2013$1,356,000
+4.1%
16,874
-0.6%
0.52%
-2.6%
Q3 2013$1,302,000
+7.5%
16,978
-0.9%
0.54%
+3.1%
Q2 2013$1,211,00017,1280.52%
Other shareholders
NOVARTIS A G shareholders Q1 2022
NameSharesValueWeighting ↓
Newman Dignan & Sheerar, Inc. 3,739$353,074,00056.77%
Susquehanna International Securities, Ltd. 118,837$11,222,0008.15%
MANAGED ASSET PORTFOLIOS, LLC 336,762$31,800,0005.59%
Martin Investment Management, LLC 169,019$15,960,0005.10%
SCHARF INVESTMENTS, LLC 1,197,539$113,083,0004.26%
GARLAND CAPITAL MANAGEMENT INC 50,705$4,788,0004.06%
Mawer Investment Management Ltd. 6,625,594$625,655,0003.69%
SPHERA FUNDS MANAGEMENT LTD. 429,000$40,510,0003.60%
First Fiduciary Investment Counsel, Inc. 196,693$18,574,0003.48%
PROFESSIONAL ADVISORY SERVICES INC 227,971$21,527,0003.46%
View complete list of NOVARTIS A G shareholders